MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, TNGX has $398,690K in assets. $52,511K in debts. $112,279K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
1631.79%
Quick Ratio
1631.79%
Cash Ratio
517.92%
Debt to Asset Ratio
13.17%
Unit: Thousand (K) dollars
Assets Breakdown
    • Marketable securities
    • Cash and cash equivalents
    • Operating lease right-of-use ass...
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Operating lease liabilities, net...
    • Others

Balance Sheets
2025-12-31
2024-12-31
2023-12-31
2022-12-31
Cash and cash equivalents
112,279 69,530 66,385 59,968
Marketable securities
230,859 188,387 270,500 306,165
Accounts receivable
---2,000
Restricted cash
428 -856 567
Prepaid expenses and other current assets
10,190 8,426 8,797 6,572
Total current assets
353,756 266,343 346,538 375,272
Property, plant and equipment, gross
17,406 16,465 15,897 14,565
Less accumulated depreciation
10,538 8,363 5,989 3,681
Property and equipment, net
6,868 8,102 9,908 10,884
Operating lease right-of-use assets
35,624 39,476 43,508 46,886
Restricted cash, net of current portion
2,139 2,567 2,567 3,423
Other assets
303 4 46 5
Total assets
398,690 316,492 402,567 436,470
Accounts payable
1,182 1,601 2,785 4,453
Accrued expenses and other current liabilities
17,759 16,497 15,401 17,495
Operating lease liabilities
2,738 2,454 2,082 1,770
Deferred revenue
0 17,618 25,670 31,792
Income tax payable
---35
Total current liabilities
21,679 38,170 45,938 55,545
Operating lease liabilities, net of current portion
30,832 34,039 36,838 39,361
Deferred revenue, net of current portion
0 44,766 66,683 92,088
Total liabilities
52,511 116,975 149,459 186,994
Common stock, 0.001 par value 400,000,000 and 200,000,000 shares authorized at december 31, 2025 and december 31, 2024, respectively 135,940,454 and 107,729,343 shares issued and outstanding as of december 31, 2025 and 2024, respectively
136 108 102 88
Additional paid-in capital
948,971 700,631 624,076 522,605
Accumulated other comprehensive income
224 336 186 -3,705
Accumulated deficit
-603,152 -501,558 -371,256 -269,512
Total stockholders' equity
346,179 199,517 253,108 249,476
Total liabilities and stockholders' equity
398,690 316,492 402,567 436,470
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Marketable securities$230,859K (22.55%↑ Y/Y)Cash and cashequivalents$112,279K (61.48%↑ Y/Y)Prepaid expenses andother current assets$10,190K (20.94%↑ Y/Y)Restricted cash$428K Property, plant andequipment, gross$17,406K (5.72%↑ Y/Y)Total current assets$353,756K (32.82%↑ Y/Y)Operating leaseright-of-use assets$35,624K (-9.76%↓ Y/Y)Property and equipment,net$6,868K (-15.23%↓ Y/Y)Restricted cash, net ofcurrent portion$2,139K (-16.67%↓ Y/Y)Other assets$303K (7475.00%↑ Y/Y)Less accumulateddepreciation$10,538K (26.01%↑ Y/Y)Total assets$398,690K (25.97%↑ Y/Y)Total liabilities andstockholders' equity$398,690K (25.97%↑ Y/Y)Total stockholders'equity$346,179K (73.51%↑ Y/Y)Total liabilities$52,511K (-55.11%↓ Y/Y)Accumulated deficit-$603,152K (-20.26%↓ Y/Y)Additional paid-in capital$948,971K (35.45%↑ Y/Y)Operating leaseliabilities, net of current...$30,832K (-9.42%↓ Y/Y)Total currentliabilities$21,679K (-43.20%↓ Y/Y)Accumulated othercomprehensive income$224K (-33.33%↓ Y/Y)Common stock, 0.001 parvalue 400,000,000 and...$136K (25.93%↑ Y/Y)Accrued expenses andother current...$17,759K (7.65%↑ Y/Y)Operating leaseliabilities$2,738K (11.57%↑ Y/Y)Accounts payable$1,182K (-26.17%↓ Y/Y)

TNGX_BIG

Tango Therapeutics, Inc. (TNGX)

TNGX_BIG

Tango Therapeutics, Inc. (TNGX)